Zobrazeno 1 - 10 of 602 pro vyhledávání: '"Bawa, O"'
1
Akademický článek
DiPRO1 distinctly reprograms muscle and mesenchymal cancer cells.
Autor: Rich J; UMR8126 CNRS, Gustave Roussy Cancer campus, Université Paris-Saclay, Villejuif, France., Bennaroch M; UMR8126 CNRS, Gustave Roussy Cancer campus, Université Paris-Saclay, Villejuif, France., Notel L; UMR8126 CNRS, Gustave Roussy Cancer campus, Université Paris-Saclay, Villejuif, France., Patalakh P; UMR8126 CNRS, Gustave Roussy Cancer campus, Université Paris-Saclay, Villejuif, France., Alberola J; UMR8126 CNRS, Gustave Roussy Cancer campus, Université Paris-Saclay, Villejuif, France., Issa F; INSERM U1016, CNRS UMR 8104, Institut Cochin, Université Paris-Cité, Paris, France., Opolon P; Pathology and Cytology Section, UMS AMMICA, CNRS, INSERM, Gustave Roussy Cancer campus, Université Paris-Saclay, Villejuif, France., Bawa O; Pathology and Cytology Section, UMS AMMICA, CNRS, INSERM, Gustave Roussy Cancer campus, Université Paris-Saclay, Villejuif, France., Rondof W; Bioinformatics Platform, UMS AMMICA, CNRS, INSERM, Gustave Roussy Cancer campus, Université Paris-Saclay, Villejuif, France.; Department of Pediatric and Adolescent Oncology, Gustave Roussy Cancer campus, INSERM U1015, Université Paris-Saclay, Villejuif, France., Marchais A; Bioinformatics Platform, UMS AMMICA, CNRS, INSERM, Gustave Roussy Cancer campus, Université Paris-Saclay, Villejuif, France.; Department of Pediatric and Adolescent Oncology, Gustave Roussy Cancer campus, INSERM U1015, Université Paris-Saclay, Villejuif, France., Dessen P; Bioinformatics Platform, UMS AMMICA, CNRS, INSERM, Gustave Roussy Cancer campus, Université Paris-Saclay, Villejuif, France., Meurice G; Bioinformatics Platform, UMS AMMICA, CNRS, INSERM, Gustave Roussy Cancer campus, Université Paris-Saclay, Villejuif, France., Le-Gall M; Proteom'IC facility, Université Paris Cité, CNRS, INSERM, Institut Cochin, F-75014, Paris, France., Polrot M; Pre-clinical Evaluation Unit (PFEP), INSERM, Gustave Roussy Cancer campus, Université Paris-Saclay, Villejuif, France., Ser-Le Roux K; Pre-clinical Evaluation Unit (PFEP), INSERM, Gustave Roussy Cancer campus, Université Paris-Saclay, Villejuif, France., Mamchaoui K; Sorbonne Université, Inserm, Institut de Myologie, Centre de Recherche en Myologie, F-75013, Paris, France., Droin N; Genomic Platform, UMS AMMICA US 23 INSERM UAR 3655 CNRS, Gustave Roussy Cancer campus, Université Paris-Saclay, Villejuif, France.; UMR1287 INSERM, Gustave Roussy Cancer campus, Université Paris-Saclay, Villejuif, France., Raslova H; UMR1287 INSERM, Gustave Roussy Cancer campus, Université Paris-Saclay, Villejuif, France., Maire P; INSERM U1016, CNRS UMR 8104, Institut Cochin, Université Paris-Cité, Paris, France., Geoerger B; Department of Pediatric and Adolescent Oncology, Gustave Roussy Cancer campus, INSERM U1015, Université Paris-Saclay, Villejuif, France., Pirozhkova I; UMR8126 CNRS, Gustave Roussy Cancer campus, Université Paris-Saclay, Villejuif, France. iryna.pirozhkova@cnrs.fr.; INSERM U1016, CNRS UMR 8104, Institut Cochin, Université Paris-Cité, Paris, France. iryna.pirozhkova@cnrs.fr.
Publikováno v: EMBO molecular medicine [EMBO Mol Med] 2024 Aug; Vol. 16 (8), pp. 1840-1885. Date of Electronic Publication: 2024 Jul 15.
Zobrazit plný text záznamu
2
Akademický článek
Nonpersistent Nanoarchitectures Enhance Concurrent Chemoradiotherapy in an Immunocompetent Orthotopic Model of HPV+ Head/Neck Carcinoma.
Autor: Gonnelli A; Center for Nanotechnology Innovation@NEST, Istituto Italiano di Tecnologia, Piazza San Silvestro 12, Pisa, 56127, Italy.; Radiation Oncology Unit, Pisa University Hospital 'Azienda Ospedaliero-Universitaria Pisana', Via Roma 67, Pisa, 56126, Italy., Gerbé de Thoré M; Gustave Roussy, INSERM U1030 Molecular Radiotherapy and Therapeutic Innovation, Université Paris Saclay, 114, rue Edouard Vaillant, Villejuif Cedex, 94805, France., Ermini ML; Center for Nanotechnology Innovation@NEST, Istituto Italiano di Tecnologia, Piazza San Silvestro 12, Pisa, 56127, Italy., Frusca V; Center for Nanotechnology Innovation@NEST, Istituto Italiano di Tecnologia, Piazza San Silvestro 12, Pisa, 56127, Italy.; Scuola Superiore Sant'Anna, Piazza Martiri della Libertà 33, Pisa, 56127, Italy., Zamborlin A; Center for Nanotechnology Innovation@NEST, Istituto Italiano di Tecnologia, Piazza San Silvestro 12, Pisa, 56127, Italy.; NEST-Scuola Normale Superiore, Piazza San Silvestro 12, Pisa, 56127, Italy., Signolle N; Gustave Roussy, Plateforme de pathologie expérimentale et translationnelle, UMS AMMICA, 114, rue Edouard Vaillant, Villejuif Cedex, 94805, France., Bawa O; Gustave Roussy, Plateforme de pathologie expérimentale et translationnelle, UMS AMMICA, 114, rue Edouard Vaillant, Villejuif Cedex, 94805, France., Clémenson C; Gustave Roussy, INSERM U1030 Molecular Radiotherapy and Therapeutic Innovation, Université Paris Saclay, 114, rue Edouard Vaillant, Villejuif Cedex, 94805, France., Meziani L; Gustave Roussy, INSERM U1030 Molecular Radiotherapy and Therapeutic Innovation, Université Paris Saclay, 114, rue Edouard Vaillant, Villejuif Cedex, 94805, France., Bergeron P; Gustave Roussy, INSERM U1030 Molecular Radiotherapy and Therapeutic Innovation, Université Paris Saclay, 114, rue Edouard Vaillant, Villejuif Cedex, 94805, France., El-Azrak I; Gustave Roussy, INSERM U1030 Molecular Radiotherapy and Therapeutic Innovation, Université Paris Saclay, 114, rue Edouard Vaillant, Villejuif Cedex, 94805, France., Sarogni P; Center for Nanotechnology Innovation@NEST, Istituto Italiano di Tecnologia, Piazza San Silvestro 12, Pisa, 56127, Italy., Mugnaioli E; Department of Earth Sciences, University of Pisa, Via S. Maria 53, Pisa, 56126, Italy., Giannini N; Center for Nanotechnology Innovation@NEST, Istituto Italiano di Tecnologia, Piazza San Silvestro 12, Pisa, 56127, Italy.; Radiation Oncology Unit, Pisa University Hospital 'Azienda Ospedaliero-Universitaria Pisana', Via Roma 67, Pisa, 56126, Italy., Drava G; Department of Pharmacy, School of Medical and Pharmaceutical Sciences, University of Genoa, Viale Cembrano 4, Genoa, 16148, Italy., Deutsch E; Gustave Roussy, INSERM U1030 Molecular Radiotherapy and Therapeutic Innovation, Université Paris Saclay, 114, rue Edouard Vaillant, Villejuif Cedex, 94805, France., Paiar F; Radiation Oncology Unit, Pisa University Hospital 'Azienda Ospedaliero-Universitaria Pisana', Via Roma 67, Pisa, 56126, Italy., Mondini M; Gustave Roussy, INSERM U1030 Molecular Radiotherapy and Therapeutic Innovation, Université Paris Saclay, 114, rue Edouard Vaillant, Villejuif Cedex, 94805, France., Voliani V; Center for Nanotechnology Innovation@NEST, Istituto Italiano di Tecnologia, Piazza San Silvestro 12, Pisa, 56127, Italy.; Department of Pharmacy, School of Medical and Pharmaceutical Sciences, University of Genoa, Viale Cembrano 4, Genoa, 16148, Italy.
Publikováno v: Advanced materials (Deerfield Beach, Fla.) [Adv Mater] 2024 Jul; Vol. 36 (28), pp. e2400949. Date of Electronic Publication: 2024 May 27.
Zobrazit plný text záznamu
3
Pre-service Accounting education teachers’ experiences of active learning through group work at a university in South Africa
Autor: Ngwenya, J. C., Arek-Bawa, O. O.
Publikováno v: South African Journal of Higher Education, Volume: 36, Issue: 3, Pages: 159-176, Published: JUL 2022
This article explores pre-service teachers’ experiences of active learning through group work in Accounting Education. The study employed a qualitative case study. Data were obtained through semi-structured individual and focus group interviews fro
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c38988542e2502cda48d91111391d225
https://doi.org/10.20853/36-3-4670
Zobrazit plný text záznamu
4
Akademický článek
Antitumoral effect of local injection of TLR-9 agonist emulsified in Lipiodol with systemic anti-PD-1 in a murine model of colorectal carcinoma.
Autor: Grindel AL; EA4340 Biomarqueurs en oncologie et onco-hématologie (BECCOH), Université Paris Saclay, Versailles, France., Fretellier N; Guerbet, Research and Innovation Division, Aulnay-sous-Bois, France., Soares M; Guerbet, Research and Innovation Division, Aulnay-sous-Bois, France., Bouzakher N; EA4340 Biomarqueurs en oncologie et onco-hématologie (BECCOH), Université Paris Saclay, Versailles, France., Millot Maysounabe V; Guerbet, Research and Innovation Division, Aulnay-sous-Bois, France., Santus R; Guerbet, Research and Innovation Division, Aulnay-sous-Bois, France., Bawa O; INSERM US23 Analyse Moléculaire, Modélisation et Imagerie de la Maladie Cancéreuse (AMMICA), Villejuif, France., Wintrebert M; Guerbet, Research and Innovation Division, Aulnay-sous-Bois, France., Couquelet C; Guerbet, Research and Innovation Division, Aulnay-sous-Bois, France., Robert P; Guerbet, Research and Innovation Division, Aulnay-sous-Bois, France., Emile JF; EA4340 Biomarqueurs en oncologie et onco-hématologie (BECCOH), Université Paris Saclay, Versailles, France.; Département d'anatomie Pathologique et de Cytologie, Hôpital Ambroise-Paré, Boulogne-Billancourt, France., Capron C; EA4340 Biomarqueurs en oncologie et onco-hématologie (BECCOH), Université Paris Saclay, Versailles, France.; Immunology and Hematology Department, Hôpital Ambroise Paré, Boulogne-Billancourt, France.
Publikováno v: Frontiers in immunology [Front Immunol] 2024 Jan 16; Vol. 14, pp. 1272246. Date of Electronic Publication: 2024 Jan 16 (Print Publication: 2023).
Zobrazit plný text záznamu
5
Editorial & Opinion
Molecular profiling of biliary tract cancers reveals distinct genomic landscapes between circulating and tissue tumor DNA.
Autor: Astier C; ERC Chromatin Remodeling, DNA Repair and Epigenetics Laboratory, INSERM U981, Gustave Roussy, Villejuif, France.; Université Paris-Saclay, Université Paris-Sud XI, Faculté de Médicine, Le Kremlin Bicêtre, France., Ngo C; ERC Chromatin Remodeling, DNA Repair and Epigenetics Laboratory, INSERM U981, Gustave Roussy, Villejuif, France.; Department of Pathology, Gustave Roussy, Villejuif, France., Colmet-Daage L; ERC Chromatin Remodeling, DNA Repair and Epigenetics Laboratory, INSERM U981, Gustave Roussy, Villejuif, France., Marty V; INSERM US23, CNRS UAR 3655, AMMICa, Experimental and Translational Pathology Platform, Gustave Roussy, Villejuif, France., Bawa O; INSERM US23, CNRS UAR 3655, AMMICa, Experimental and Translational Pathology Platform, Gustave Roussy, Villejuif, France., Nicotra C; Drug Development Department (DITEP), Gustave Roussy - Cancer Campus, Villejuif, France., Ngo-Camus M; Drug Development Department (DITEP), Gustave Roussy - Cancer Campus, Villejuif, France., Italiano A; Drug Development Department (DITEP), Gustave Roussy - Cancer Campus, Villejuif, France.; Department of Early Phase Trial Unit, Institut Bergonié Comprehensive Cancer Centre, Bordeaux, France.; Faculty of Medicine, University of Bordeaux, Bordeaux, France., Massard C; Drug Development Department (DITEP), Gustave Roussy - Cancer Campus, Villejuif, France.; INSERM U1030, Molecular Radiotherapy, Gustave Roussy, Université Paris-Saclay, Paris, France., Scoazec JY; INSERM US23, CNRS UAR 3655, AMMICa, Experimental and Translational Pathology Platform, Gustave Roussy, Villejuif, France.; Department of Pathology and Laboratory Medicine, Translational Research Laboratory and Biobank, AMMICA, INSERM US23/CNRS UMS3655, Gustave Roussy, Villejuif, France., Smolenschi C; Drug Development Department (DITEP), Gustave Roussy - Cancer Campus, Villejuif, France., Ducreux M; Drug Development Department (DITEP), Gustave Roussy - Cancer Campus, Villejuif, France.; Université Paris-Saclay, Gustave Roussy, INSERM, Dynamique des Cellules Tumorales (U-1279), Villejuif, France., Hollebecque A; Drug Development Department (DITEP), Gustave Roussy - Cancer Campus, Villejuif, France., Postel-Vinay S; ERC Chromatin Remodeling, DNA Repair and Epigenetics Laboratory, INSERM U981, Gustave Roussy, Villejuif, France. sophie.postel-vinay@gustaveroussy.fr.; Drug Development Department (DITEP), Gustave Roussy - Cancer Campus, Villejuif, France. sophie.postel-vinay@gustaveroussy.fr.; University College of London Cancer Institute, London, UK. sophie.postel-vinay@gustaveroussy.fr.; Institut Gustave Roussy, 114 rue Edouard Vaillant, 94805, Villejuif, France. sophie.postel-vinay@gustaveroussy.fr.
Publikováno v: Experimental hematology & oncology [Exp Hematol Oncol] 2024 Jan 08; Vol. 13 (1), pp. 2. Date of Electronic Publication: 2024 Jan 08.
Zobrazit plný text záznamu
6
Akademický článek
Biomarker Identification in Liver Cancers Using Desorption Electrospray Ionization Mass Spectrometry (DESI-MS) Imaging: An Approach for Spatially Resolved Metabolomics.
Autor: Chen H; Centre de Recherche des Cordeliers, Equipe labellisée par la Ligue contre le cancer, Inserm U1138, Université Paris Cité, Sorbonne Université, Institut Universitaire de France, Paris, France.; Metabolomics and Cell Biology Platforms, UMS AMICCa, Gustave Roussy, Villejuif, France.; Faculté de Médecine, Université de Paris Saclay, Kremlin Bicêtre, France., Durand S; Centre de Recherche des Cordeliers, Equipe labellisée par la Ligue contre le cancer, Inserm U1138, Université Paris Cité, Sorbonne Université, Institut Universitaire de France, Paris, France.; Metabolomics and Cell Biology Platforms, UMS AMICCa, Gustave Roussy, Villejuif, France., Bawa O; PETRA, UMS AMICCa, Gustave Roussy, Villejuif, France., Bourgin M; Centre de Recherche des Cordeliers, Equipe labellisée par la Ligue contre le cancer, Inserm U1138, Université Paris Cité, Sorbonne Université, Institut Universitaire de France, Paris, France.; Metabolomics and Cell Biology Platforms, UMS AMICCa, Gustave Roussy, Villejuif, France., Montégut L; Centre de Recherche des Cordeliers, Equipe labellisée par la Ligue contre le cancer, Inserm U1138, Université Paris Cité, Sorbonne Université, Institut Universitaire de France, Paris, France.; Metabolomics and Cell Biology Platforms, UMS AMICCa, Gustave Roussy, Villejuif, France.; Faculté de Médecine, Université de Paris Saclay, Kremlin Bicêtre, France., Lambertucci F; Centre de Recherche des Cordeliers, Equipe labellisée par la Ligue contre le cancer, Inserm U1138, Université Paris Cité, Sorbonne Université, Institut Universitaire de France, Paris, France.; Metabolomics and Cell Biology Platforms, UMS AMICCa, Gustave Roussy, Villejuif, France., Motiño O; Centre de Recherche des Cordeliers, Equipe labellisée par la Ligue contre le cancer, Inserm U1138, Université Paris Cité, Sorbonne Université, Institut Universitaire de France, Paris, France.; Metabolomics and Cell Biology Platforms, UMS AMICCa, Gustave Roussy, Villejuif, France., Li S; Centre de Recherche des Cordeliers, Equipe labellisée par la Ligue contre le cancer, Inserm U1138, Université Paris Cité, Sorbonne Université, Institut Universitaire de France, Paris, France.; Metabolomics and Cell Biology Platforms, UMS AMICCa, Gustave Roussy, Villejuif, France.; Faculté de Médecine, Université de Paris Saclay, Kremlin Bicêtre, France., Nogueira-Recalde U; Centre de Recherche des Cordeliers, Equipe labellisée par la Ligue contre le cancer, Inserm U1138, Université Paris Cité, Sorbonne Université, Institut Universitaire de France, Paris, France.; Metabolomics and Cell Biology Platforms, UMS AMICCa, Gustave Roussy, Villejuif, France.; Rheumatology Research Group (GIR), Biomedical Research Institute of A Coruña (INIBIC), Professor Novoa Santos Foundation, A Coruña, Spain., Anagnostopoulos G; Centre de Recherche des Cordeliers, Equipe labellisée par la Ligue contre le cancer, Inserm U1138, Université Paris Cité, Sorbonne Université, Institut Universitaire de France, Paris, France.; Metabolomics and Cell Biology Platforms, UMS AMICCa, Gustave Roussy, Villejuif, France., Maiuri MC; Centre de Recherche des Cordeliers, Equipe labellisée par la Ligue contre le cancer, Inserm U1138, Université Paris Cité, Sorbonne Université, Institut Universitaire de France, Paris, France.; Metabolomics and Cell Biology Platforms, UMS AMICCa, Gustave Roussy, Villejuif, France.; Department of Molecular Medicine and Medical Biotechnologies, University of Napoli Federico II, Naples, Italy., Kroemer G; Centre de Recherche des Cordeliers, Equipe labellisée par la Ligue contre le cancer, Inserm U1138, Université Paris Cité, Sorbonne Université, Institut Universitaire de France, Paris, France.; Metabolomics and Cell Biology Platforms, UMS AMICCa, Gustave Roussy, Villejuif, France.; Institut du Cancer Paris CARPEM, Department of Biology, Hôpital Européen Georges Pompidou, AP-HP, Paris, France., Martins I; Centre de Recherche des Cordeliers, Equipe labellisée par la Ligue contre le cancer, Inserm U1138, Université Paris Cité, Sorbonne Université, Institut Universitaire de France, Paris, France. isabelle.martins@inserm.fr.; Metabolomics and Cell Biology Platforms, UMS AMICCa, Gustave Roussy, Villejuif, France. isabelle.martins@inserm.fr.
Publikováno v: Methods in molecular biology (Clifton, N.J.) [Methods Mol Biol] 2024; Vol. 2769, pp. 199-209.
Zobrazit plný text záznamu
8
Assessment in textbooks: exploring cognitive demand in first-year accounting textbooks
Autor: Ngwenya, J. C., Arek-Bawa, O. O.
Publikováno v: South African Journal of Higher Education, Volume: 34, Issue: 1, Pages: 176-196, Published: 2020
The South African higher education program expects to develop graduates with high cognitive skills. This is endorsed further by the expectations of high cognitive attributes for entry level members from the Accounting professional bodies. Although le
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______1575::61d65d627658345230e43012dd20b4a9
http://www.scielo.org.za/scielo.php?script=sci_arttext&pid=S1753-59132020000100010&lng=en&tlng=en
Zobrazit plný text záznamu
9
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje